| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |